Publications by authors named "Hiroya Takiuchi"

Claim this Profile
G
Gingival Pigmentation Affected by Smoking among Different Age Groups: A Quantitative Analysis of Gingival Pigmentation Using Clinical Oral Photographs.
Tomotaka Kato, Shinsuke Mizutani, Hiroya Takiuchi, Seiichi Sugiyama, Takashi Hanioka

Int J Environ Res Public Health· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of Reduced Gingival Melanosis after Smoking Cessation: A Novel Analysis of Gingival Pigmentation Using Clinical Oral Photographs.
Tomotaka Kato, Hiroya Takiuchi, Seiichi Sugiyama, Michiko Makino, Satoshi Noguchi

Int J Environ Res Public Health· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ca-channel blocker-induced gingival overgrowth that improved with non-surgical therapy during visiting care: a case report.
Tomotaka Kato, Hiroya Takiuchi, Masahiro Yamaguchi, Toru Naito

Gerodontology· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society.
Hiroyuki Kuwano, Yasumasa Nishimura, Tsuneo Oyama, Hiroyuki Kato, Yuko Kitagawa, Hiroya Takiuchi

Esophagus· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404).
Hiroshi Imamura, Tomono Kishimoto, Hiroya Takiuchi, Yutaka Kimura, Takashi Morimoto

J Chemother· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Serotonin syndrome in a patient with small cell lung cancer].
Chieko Takahashi, Emi Goto, Sachiko Taira, Noriaki Kataoka, Masami Nishihara, Hiroya Takiuchi

Gan To Kagaku Ryoho· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
Kensei Yamaguchi, Akira Sawaki, Toshihiko Doi, Taroh Satoh, Yasuhide Yamada, Hiroya Takiuchi

Gastric Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Yutaka Kimura, Hiroshi Yano, Hiroshi Imamura, Kazumasa Fujitani, Motohiro Imano, Hiroya Takiuchi

Jpn J Clin Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A problem-based learning tutorial for dental students regarding elderly residents in a nursing home in Japan.
Yoshizo Matsuka, Ryu Nakajima, Haruna Miki, Aya Kimura, Manabu Kanyama, Hiroya Takiuchi

J Dent Educ· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Comparison of chemotherapy side effects between elderly and young subjects].
Emi Goto, Makoto Hosomi, Masami Nishihara, Masahiro Goto, Motoki Yoshida, Hiroya Takiuchi

Gan To Kagaku Ryoho· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase II study of the stop-and-go modified FOLFOX6 with bevacizumab for first-line treatment of patients with metastatic colorectal cancer.
Natsuko T Okita, Taito Esaki, Eishi Baba, Daisuke Sakai, Shinya Tokunaga, Hiroya Takiuchi

Invest New Drugs· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study.
Akira Sawaki, Yasuo Ohashi, Yasushi Omuro, Taroh Satoh, Yasuo Hamamoto, Hiroya Takiuchi

Gastric Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of electrolysis for detoxification of an antineoplastic in urine.
Toyohide Kobayashi, Jun Hirose, Kouichi Sano, Ryuji Kato, Yoshio Ijiri, Hiroya Takiuchi

Ecotoxicol Environ Saf· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of docetaxel, cisplatin and 5-fluorouracil (DCF) for metastatic esophageal cancer (OGSG 0403).
Shigeyuki Tamura, Motohiro Imano, Hiroya Takiuchi, Kenji Kobayashi, Haruhiko Imamoto

Anticancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.
Toshiaki Watanabe, Michio Itabashi, Yasuhiro Shimada, Shinji Tanaka, Yoshinori Ito, Hiroya Takiuchi

Int J Clin Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
Ken Kato, Kei Muro, Keiko Minashi, Atsushi Ohtsu, Satoshi Ishikura, Hiroya Takiuchi

Int J Radiat Oncol Biol Phys· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chemotherapy for gastrointestinal cancer in elderly patients].
Hitoshi Nishitani, Hiroya Takiuchi, Ken Asaishi, Shin Kuwakado, Takayuki Kii

Gan To Kagaku Ryoho· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial).
Tetsuya Hamaguchi, Kuniaki Shirao, Atsushi Ohtsu, Ichinosuke Hyodo, Yasuaki Arai, Hiroya Takiuchi

Gastric Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line chemotherapy for gastric cancer: a new issue lies ahead in global trials.
Hiroya Takiuchi

Gastric Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].
Atsushi Sato, Toshihiko Doi, Narikazu Boku, Ken Kato, Yoshito Komatsu, Hiroya Takiuchi

Gan To Kagaku Ryoho· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Efficacy of monoclonal antibodies in combination with chemotherapy in metastatic colorectal cancer].
Hiroya Takiuchi

Nihon Rinsho· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan is inactive as a first-line treatment, but plays an important part in gastric cancer treatment.
Hiroya Takiuchi

Gastric Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lower G. I./colon and rectum cancer. IV. Standard chemotherapy of advanced, recurrent colonic cancer].
Hiroya Takiuchi

Gan To Kagaku Ryoho· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current status and perspectives of biologics in the treatment of metastatic colorectal cancer].
Hiroya Takiuchi

Nihon Rinsho· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
Kei Muro, Narikazu Boku, Yasuhiro Shimada, Akihito Tsuji, Shinichi Sameshima, Hiroya Takiuchi

Lancet Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis